Tumor that causes type of early puberty in boys is linked to gene mutation

December 01, 1999

CHICAGO --- A newly found mutation in a gene that helps the body produce testosterone has been linked to Leydig cell adenoma, a rare testicular tumor that causes early puberty in boys.

The gene defect was identified by a research team headed by Andrew Shenker, M.D., of Northwestern University Medical School, and described in an article in the Dec. 2 issue of The New England Journal of Medicine.

The gene codes for a protein called luteinizing hormone (LH) receptor. Under normal conditions, the LH receptor receives a message from the pituitary gland and signals Leydig cells to make testosterone and initiate puberty.

In the mutated form, the LH receptor causes rapid growth (hyperplasia) of Leydig cells and overproduction of testosterone without the hormonal signals normally required from the pituitary.

Other defects in the same gene, earlier identified by Shenker and others, have been implicated in a different, inherited form of precocious puberty in boys. Here also, the malfunctioning LH receptor causes Leydig cells to multiply and make testosterone independent of signals from the pituitary.

The LH receptor is a member of a family of proteins called G-coupled protein receptors. Mutations in the genes that code for these proteins recently have been recognized as a cause of endocrine diseases.

"The effects of different mutations of the LH receptor gene may further understanding of the signal pathways involved in progression from hyperplasia to tumor growth in endocrine tissues," Shenker said.

He also said that the study of naturally occurring signaling defects not only has inherent value in understanding the molecular basis of disease, but also helps scientists understand the basic mechanisms involved in cell communication.

Shenker is an assistant professor of pediatrics and of molecular pharmacology and biological chemistry at the Medical School, a researcher at the Children's Memorial Institute for Education and Research and a member of The Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

His co-researchers were Guoquan Liu, Lise Duranteau, M.D., and Jason Monroe of Northwestern University Medical School and the Children's Memorial Institute for Education and Research; Jean-Claude Carel, M.D., Hopital Saint Vincent de Paul, Paris; and Daniel A. Doyle, M.D., Temple University Children's Medical Center, Philadelphia.

This study was supported by grants from the American Cancer Society and the National Institutes of Health, a Lavoisier Grant from the French Ministry of Foreign Affairs and a grant from the Philippe Foundation, Inc. Shenker is the Crown Family Young Investigator in Developmental Systems Biology at Children's Memorial Institute for Education and Research.
CONTACT: Elizabeth Crown at 312-503-8928 or e-mail at e-crown@nwu.edu
Broadcast Media Contact: Stephanie Clemson at 847-491-4888 or s-clemson@nwu.edu

Northwestern News on the World Wide Web: http://www.nwu.edu/univ-relations/media/

Northwestern University

Related Testosterone Articles from Brightsurf:

ACP issues guideline for testosterone treatment in adult men with age-related low testosterone
Physicians should prescribe testosterone for men with age-related low testosterone only to treat sexual dysfunction, the American College of Physicians (ACP) says in a new evidence-based clinical practice guideline.

Women with asthma appear more likely to have lower levels of testosterone
Women with asthma appear more likely to have lower levels of 'free' (not attached to proteins) testosterone than women who do not have asthma, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Penis development needs more than just testes and testosterone
Proper development of the fetal penis requires not just testosterone from the testes, but a second hormone produced by other tissues, including the placenta, according to a new study publishing Feb.

Testosterone treatment over 10 years can improve or reverse type 2 diabetes in men with low testosterone, and induce significant weight loss
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) reveals that in men with low testosterone who have type 2 diabetes (T2D), testosterone therapy can improve their disease and reverse its progress, and can also induce significant weight loss.

Testosterone replacement therapy may slow the progression of COPD
GALVESTON, Texas -- Researchers from The University of Texas Medical Branch at Galveston found that testosterone replacement therapy may slow disease progression of chronic obstructive pulmonary disease.

Testosterone research brings new hope for cancer patients
Approximately 20 percent of cancer related deaths are attributed to the syndrome of cachexia.

Testosterone prescriptions have sharply dropped in the past few years
Testosterone use in the United States tripled between 2001 and 2011, mostly in men without a clear indication for it.

Use of prescribed testosterone therapy in US decreases in recent years
Testosterone use in the United States tripled from 2001 through 2011, mostly in men without a clear indication.

Testosterone causes men to desire luxury goods
Researchers examine testosterone's effect on men's desire for goods that are considered to have social cachet.

Men's testosterone levels largely determined by where they grow up
Men's testosterone levels are largely determined by their environment during childhood, according to new research.

Read More: Testosterone News and Testosterone Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.